Squamous cell carcinoma of the lung natural history, complications, and prognosis

Jump to navigation Jump to search

Squamous Cell Carcinoma of the Lung Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Squamous Cell Carcinoma of the Lung from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Squamous cell carcinoma of the lung natural history, complications, and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Squamous cell carcinoma of the lung natural history, complications, and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Squamous cell carcinoma of the lung natural history, complications, and prognosis

CDC on Squamous cell carcinoma of the lung natural history, complications, and prognosis

Squamous cell carcinoma of the lung natural history, complications, and prognosis in the news

Blogs on Squamous cell carcinoma of the lung natural history, complications, and prognosis

Directions to Hospitals Treating Squamous cell carcinoma of the lung

Risk calculators and risk factors for Squamous cell carcinoma of the lung natural history, complications, and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2] Maria Fernanda Villarreal, M.D. [3]

Overview

If left untreated, squamous cell carcinoma of the lung progression occurs slowly and is then followed by local invasion to lymph nodes and distant metastasis. Common sites of metastasis include liver, adrenal gland, bone, and brain. Complications of squamous cell carcinoma of the lung, include pneumonia, pleural effusion, metastasis, and Horner's syndrome. The 5-year survival rate of patients with squamous cell carcinoma of the lung, depends on the stage at diagnosis. The average survival rate ranges from 49% to 16%. Prognosis is generally regarded as poor, the 5-year recurrence rate of squamous cell carcinoma of the lung is 24%.

Natural History, Complications, and Prognosis

Natural History

  • The majority of patients with squamous cell carcinoma of the lung are initially asymptomatic.[1]
  • The symptoms of squamous cell carcinoma of the lung usually develop in adult patients between 55 to 60 years
  • Patients with squamous cell carcinoma of the lung may also experience non-specific symptoms, such as: chronic cough, hemoptysis, dyspnea, chest pain, dysphonia, dysphagia, lack of appetite, and fatigue.[2]
  • If left untreated, patients with non-small cell lung cancer may develop local invasion to lymph nodes and distant metastasis
  • Common sites of metastasis include adrenal gland, bone, brain, and liver
  • Patients with advanced squamous cell carcinoma of the lung may develop symptoms, such as: paresthesias, bladder dysfunction, seizures, hemiplegia, cranial nerve palsies, confusion , personality changes, skeletal pain, and pleuritic pain.[2]

Complications

  • Common complications of squamous cell carcinoma of the lung, include:[1]

Prognosis

  • The presence of metastasis is associated with a particularly poor prognosis
  • The 5-year survival rate of patients with squamous cell carcinoma of the lung, depends on the stage at diagnosis
  • The average survival rate ranges from 49% to 16%.[1]
  • Features associated with worse prognosis, include:
  • Prognosis is generally regarded as poor, the 5-year recurrence rate of squamous cell carcinoma of the lung is 15%.[1]

References

  1. 1.0 1.1 1.2 1.3 Soares M, Darmon M, Salluh JI, Ferreira CG, Thiéry G, Schlemmer B, Spector N, Azoulay E (2007). "Prognosis of lung cancer patients with life-threatening complications". Chest. 131 (3): 840–6. doi:10.1378/chest.06-2244. PMID 17356101.
  2. 2.0 2.1 Leary, A (2012). Lung cancer a multidisciplinary approach. Chichester, West Sussex, UK Ames, Iowa: Wiley-Blackwell. ISBN 9781405180757.


Template:WikiDoc Sources